- Trials with a EudraCT protocol (45)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
45 result(s) found for: Parasitic Infection.
Displaying page 1 of 3.
EudraCT Number: 2015-001226-42 | Sponsor Protocol Number: MEBENDAZOLGAI3002 | Start Date*: 2015-04-09 | |||||||||||
Sponsor Name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |||||||||||||
Full Title: An Open-Label, Single-Dose Study to Assess the Safety of 500-mg Mebendazole Chewable Formulation in Children 2 to 10 Years of Age, Inclusive | |||||||||||||
Medical condition: Soil-transmitted helminth (STH) infections | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003789-21 | Sponsor Protocol Number: MULTBENZ | Start Date*: 2017-01-11 | |||||||||||
Sponsor Name:Fundación Hospital Universitari Vall d'Hebron - Institut de Recerca | |||||||||||||
Full Title: Phase II trial for assessing different benznidazol regimens in the treatment of Chagas disease in adult patients on chronic phase . BERINECE project | |||||||||||||
Medical condition: Chagas Disease on chronic phase | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005008-24 | Sponsor Protocol Number: 08126 | Start Date*: 2011-07-07 | ||||||||||||||||
Sponsor Name:University of Nottingham | ||||||||||||||||||
Full Title: Worms for immune regulation of multiple sclerosis | ||||||||||||||||||
Medical condition: Relapsing Multiple Sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002723-16 | Sponsor Protocol Number: PREMIVER | Start Date*: 2018-04-20 |
Sponsor Name:Universitaetsklinikum Tuebingen | ||
Full Title: Evaluation of the potential anti-malarial effect of ivermectin: a controlled human malaria infection trial | ||
Medical condition: In spite of remarkable progress over the last 15 years, malaria continues to be a major public health problem in the developing world with an estimated 214 million cases and 438.000 deaths in 2014.... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000322-21 | Sponsor Protocol Number: TIP5 | Start Date*: 2012-05-29 |
Sponsor Name:Sanaria Inc. | ||
Full Title: Controlled human malaria infection after immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylaxis | ||
Medical condition: Controlled human malaria infection after immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylaxis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003581-20 | Sponsor Protocol Number: ALPHA | Start Date*: 2023-03-21 |
Sponsor Name:Medical University Vienna | ||
Full Title: Albendazole pharmacokinetics in plasma, intra-cystic fluid, and cystic tissue of human cystic and alveolar echinococcosis | ||
Medical condition: Albendazole is an orally administered broad-spectrum anthelmintic Drug used in treatment of human alveolar and cystic echinococcosis. To date, data on albendazole and tissue pharmacokinetics are li... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002784-24 | Sponsor Protocol Number: 2011-11 | Start Date*: 2013-09-03 |
Sponsor Name:Sacro Cuore - Don Calabria Hospital | ||
Full Title: STRONG TREAT 1 to 4 - randomized, open-label, multi centre, phase III clinical trial on multiple versus single dose of ivermectin for the treatment of strongyloidiasis | ||
Medical condition: strongyloidiasis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004321-16 | Sponsor Protocol Number: CCOA566A2417 | Start Date*: 2017-08-31 |
Sponsor Name:Novartis Pharma AG | ||
Full Title: A study of the effects of Coartem, Malarone and artesunate-mefloquine on auditory function in patients 12 years of age or older with acute uncomplicated P. falciparum malaria | ||
Medical condition: This study assessed the effects of artemether-lumefantrine on the auditory nerve pathway as assessed by Auditory Brainstem Response (ABR) and audiometric testing in acute uncomplicated Plasmodium f... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-005477-24 | Sponsor Protocol Number: VAC045 | Start Date*: 2012-02-28 |
Sponsor Name:University of Oxford | ||
Full Title: A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of Two Prime-boost Malaria Vaccine Candidates: ChAd63 and MVA encoding ME-TRAP and the same Viral Vectors encoding CS | ||
Medical condition: Plasmodium falciparum infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002645-38 | Sponsor Protocol Number: BIOMARCHA | Start Date*: 2012-09-04 |
Sponsor Name:CRESIB-Barcelona Centre for International Health Research | ||
Full Title: Evolution of serologic biomarkers and diastolic function and segmentary contractility determined by echocardiography after treatment in Chagas diseases | ||
Medical condition: The study will be held in 63 patients with chronic Chagas Disease and 63 healthy people | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024657-36 | Sponsor Protocol Number: DSR-01 | Start Date*: 2011-05-17 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Statens Serum Institut | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Metronidazol for the treatment of dientamoebiasis in children in Denmark – A randomized, placebo-controlled, double-blinded clinical trial. | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Presumed symptomatic gastrointestinal infection with the protozoan Dientamoeba fragilis. | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004523-36 | Sponsor Protocol Number: CVac-Tü3 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:University Clinics Tübingen | |||||||||||||
Full Title: Safety and protective efficacy of a simplified Plasmodium falciparum sporozoite Chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany | |||||||||||||
Medical condition: Immunization of healthy volunteers against P. falciparum infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-004143-27 | Sponsor Protocol Number: STRONG-FIX | Start Date*: 2023-09-14 | |||||||||||
Sponsor Name:Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) | |||||||||||||
Full Title: Randomized non-inferiority clinical trial to evaluate the efficacy of a single fixed dose of 18 mg ivermectin for the treatment of uncomplicated strongyloidiasis | |||||||||||||
Medical condition: Strongyloidiasis is caused by a parasite that is globally distributed in tropical and sub-tropical areas. Most patients with strongyloidiasis are asymptomatic or have mild symptoms with gastrointes... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005735-40 | Sponsor Protocol Number: BCG-EHMI | Start Date*: 2016-03-29 | |||||||||||||||||||||
Sponsor Name:Radboud university medical center | |||||||||||||||||||||||
Full Title: Safety and protective efficacy of BCG vaccination against controlled human malaria infection | |||||||||||||||||||||||
Medical condition: Plasmodium faciparum malaria prevention | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004906-14 | Sponsor Protocol Number: A0661201 | Start Date*: 2015-04-07 |
Sponsor Name:Pfizer Inc | ||
Full Title: An Open Label, Non-Comparative Study To Evaluate Parasitological Clearance Rates and Pharmacokinetics of Azithromycin and Chloroquine Following Administration of a Fixed Dose Combination of Azithro... | ||
Medical condition: Asymptomatic Parasitemia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-002255-15 | Sponsor Protocol Number: ST3073-ST3074-DM-12-002 | Start Date*: 2014-11-04 |
Sponsor Name:Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | ||
Full Title: A phase II, open-label, multicentre, pharmacokinetic, pharmacodynamics and safety study of a new paediatric eurartesim dispersible formulation and crushed film coated eurartesim tablet, in infant p... | ||
Medical condition: Uncomplicated Plasmodium falciparum malaria | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-000393-30 | Sponsor Protocol Number: VAC055 | Start Date*: 2013-05-22 |
Sponsor Name:University of Oxford | ||
Full Title: A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01B + ChAd63 and MVA encoding ME-TRAP and also ... | ||
Medical condition: Plasmodium falciparum infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004391-34 | Sponsor Protocol Number: VAC072 | Start Date*: 2019-05-24 |
Sponsor Name:University of Oxford | ||
Full Title: A Phase I/IIa Sporozoite Challenge Study to assess the safety, immunogenicity and protective efficacy of adjuvanted R21, administered in different dose schedules in healthy UK volunteers. | ||
Medical condition: Plasmodium falciparum infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2020-002102-58 | Sponsor Protocol Number: TJT2012 | Start Date*: 2020-06-12 | |||||||||||
Sponsor Name:CHU de Liège | |||||||||||||
Full Title: Mesenchymal stromal cell therapy for severe COVID-19 infection | |||||||||||||
Medical condition: Patients with severe COVID-19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002022-41 | Sponsor Protocol Number: CHAGAS-EVOL I | Start Date*: 2011-10-13 | |||||||||||
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Ramón y Cajal | |||||||||||||
Full Title: Assessment of Therapeutic Response to Benznidazole in patients with Chronic Chagas Disease by Measuring Plasma Parasite Load and the Specific Immune Response against Trypanosoma cruzi. A Randomized... | |||||||||||||
Medical condition: Chagas disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.